With your support, we have been able to fund outstanding research, leading toward cures and improved quality of life for children with cancer. Browse through more than 1,000 funded projects below.
Use the search tool to refine your results. You can also click on a heading to sort by project title, institution name, or year the grant was awarded. Click on the project title to read more information.
ALSF Funded Research Projects
|Project Title||Institution / Principal Investigator(s)||Grant Type||Year||State|
|Genetic Analysis of Pediatric Gliomas||Baylor College of Medicine / Will Parsons, MD, PhD||'A' Award Grants||2009||Texas|
|Exploring a novel immunotherapy: cooperation of endogenous CD8+ t-cells and exogenous, allogeneic CD4+ t-cells.||The Johns Hopkins University School of Medicine / Heather Symons||Young Investigator Grants||2009||Maryland|
|Expanding access to new agents for children with refractory cancers: the experimental therapeutics program at Children's Hospital of Colorado.||Children's Hospital Colorado / Lia Gore, MD||Phase I/II Infrastructure Grants||2009||Colorado|
|Epigenetic manipulation of leukemia.||Cincinnati Children's Hospital Medical Center / H. Leighton Grimes||Innovation Grants||2009||Ohio|
|Effects of CNS Treatment on the Hippocampus||University of Arizona / Ki Moore||Nurse Researcher Grants||2009||Arizona|
|DFMO-based combination therapy for the treatment of advanced stage neuroblastoma.||Cancer Research Center of Hawaii / Dana-Lynn Koomoa||Young Investigator Grants||2009||Hawaii|
|Development of a childhood leukemia translational research program.||Dana-Farber Cancer Institute / Lewis Silverman||Phase I/II Infrastructure Grants||2009||Massachusetts|
|Central Venous Catheter (CVC) - Related Bloodstream Infections in Pediatric Cancer||Children's Hospital Los Angeles / Rita Secola||Nurse Researcher Grants||2009||California|
|Biology-based clinical trials for children with cancer.||Children's Hospital of Philadelphia / Rochelle Bagatell||Phase I/II Infrastructure Grants||2009||Pennsylvania|
|BH3 profiling to define therapy resistance classes in neuroblastoma.||Children's Hospital of Philadelphia / Michael Hogarty||Innovation Grants||2009||Pennsylvania|